REGN vs SNAP · P/E 14, rev $14.34B vs rev $5.93B
Regeneron Pharmaceuticals Inc (REGN) versus Snap Inc (SNAP) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Snap Inc (SNAP) is a internet content & information company listed on NYSE. It is led by Evan Spiegel.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SNAP revenue for 2025-12-31 was $5.93B. Net income was -$460.5M. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SNAP currently screens at market cap $8.14B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SNAP currently screens at market cap $8.14B.
Not investment advice. Open the REGN and SNAP stock pages for the full models.
Not investment advice.